FDA issues notice to Hospira over medical device issues

02/14/2013 | Reuters

Hospira said it has received a notice from the FDA over certain quality concerns involving its medical devices. CEO F. Michael Ball said that while inspectors noted progress had been made, "there is still a lot of work to be done within our device operations."

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health